Inventor
REICHERT PAUL
US37 patents
⚠️ This page may combine multiple inventors who share the name “REICHERT PAUL”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
SCHERING CORP
27 patentsUS5441734AAug 15, 1995
Metal-interferon-alpha crystals
SCHERING CORP71 citations95
US5221410AJun 22, 1993
Crystal forming device
SCHERING CORP126 citations95
US6524589B1Feb 25, 2003
Compositions of hepatitis C virus NS3/NS4A complex and methods for crystallizing same
SCHERING CORP21 citations91
US6004549ADec 21, 1999
Crystalline protein controlled release compositions
SCHERING CORP51 citations91
US5972331AOct 26, 1999
Crystalline interferon alpha for pulmonary delivery and method for producing the same
SCHERING CORP65 citations91
US5602232AFeb 11, 1997
Method for producing metal-interferon-α crystals
SCHERING CORP70 citations91
US5460956AOct 24, 1995
Method for preparing interferon alpha-2 crystals
SCHERING CORP22 citations91
US7968683B1Jun 28, 2011
Factor IXa crystals, related complexes and methods
SCHERING CORP7 citations82
US5109119AApr 28, 1992
Crystalline r-h-gm-csf and method
SCHERING CORP19 citations81
US5741485AApr 21, 1998
Method for preparing zinc interferon alpha-2 crystals
SCHERING CORP9 citations72
US5358707AOct 25, 1994
Oxidized variants of GM-CSF
SCHERING CORP6 citations72
US5616555AApr 1, 1997
Crystalline r-h-GM-CSF and method
SCHERING CORP3 citations61
US7776589B1Aug 17, 2010
Polynucleotides encoding polypeptide fragments of protein kinase B gamma (AKT3)
SCHERING CORP2 citations58
US6380172B1Apr 30, 2002
Monomeric lipophilic oligosaccharide antibiotic compositions
SCHERING CORP3 citations57
US5597900AJan 28, 1997
Crystalline interleukin-4
SCHERING CORP3 citations55
US7285408B2Oct 23, 2007
Crystalline form of an n231 mutant catalytic domain of ADAM33 and methods of use thereof
SCHERING CORP0 citations51
US8034907B2Oct 11, 2011
Polynucleotides encoding soluble, stable forms of human double minute 2 polypeptides
SCHERING CORP0 citations49
US7785879B1Aug 31, 2010
Pregnane X receptor compositions, crystals and uses thereof
SCHERING CORP0 citations49
US7632920B2Dec 15, 2009
Soluble, stable form of HDM2, crystalline forms thereof and methods of use thereof
SCHERING CORP0 citations49
US7888474B2Feb 15, 2011
HDM2 polypeptides
SCHERING CORP0 citations48
US7705127B1Apr 27, 2010
HDM2 Polypeptides
SCHERING CORP0 citations48
US8048663B2Nov 1, 2011
Crystal of pregnane X receptor fused to steroid receptor coactivator-1
SCHERING CORP0 citations47
US7824491B2Nov 2, 2010
Method for crystallizing aurora 2 kinase catalytic domain polypeptide
SCHERING CORP0 citations47
US7422885B1Sep 9, 2008
Crystalline form of the catalytic domain of Aurora 2 kinase and methods of use thereof
SCHERING CORP0 citations47
US7459296B2Dec 2, 2008
Hepatitis C virus NS3 helicase subdomain I
SCHERING CORP0 citations46
US7722718B2May 25, 2010
Methods for crystallizing ERK2 polypeptides
SCHERING CORP0 citations43
US7312061B2Dec 25, 2007
ERK2 crystals
SCHERING CORP0 citations43